• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深入了解侵袭性曲霉病——从病原体到疾病。

New insights into invasive aspergillosis--from the pathogen to the disease.

机构信息

Department of Hygiene, Microbiology and Social Medicine, Division of Hygiene and Medical Microbiology, Medical University Innsbruck, Innsbruck, Tirol, Austria.

出版信息

Curr Pharm Des. 2013;19(20):3679-88. doi: 10.2174/13816128113199990366.

DOI:10.2174/13816128113199990366
PMID:23278533
Abstract

Disease manifestations with Aspergillus spp. are very diverse and dependent on interaction between the fungus and the host. Invasive aspergillosis (IA) is the most severe form of Aspergillus - associated disease found in immunocompromised hosts. Infections are mainly due to Aspergillus (A.) fumigatus, an air-borne opportunistic pathogen that causes 90% of IA. Mortality rate of this disease is still very high (50-95%), partly because of diagnostic difficulties, limited antifungal treatment options, weak conditions of patients at risk; but also in part because understanding of virulence factors involved in A. fumigatus pathogenicity and interactions of the pathogen with the host immune system is still poor. This review focuses on properties of A. fumigatus in terms of putative virulence factors and interactions of the pathogen with a main focus on the innate immune system.

摘要

疾病表现与曲霉菌属非常多样化,取决于真菌与宿主之间的相互作用。侵袭性曲霉病(IA)是免疫功能低下宿主中最严重的曲霉相关疾病。感染主要由曲霉菌(A.)烟曲霉引起,烟曲霉是一种空气传播的机会性病原体,可引起 90%的 IA。这种疾病的死亡率仍然很高(50-95%),部分原因是诊断困难、抗真菌治疗选择有限、患者病情虚弱;但部分原因还在于对烟曲霉致病性和病原体与宿主免疫系统相互作用中涉及的毒力因子的理解仍然有限。这篇综述重点介绍了烟曲霉在潜在毒力因子方面的特性,以及病原体与固有免疫系统的相互作用。

相似文献

1
New insights into invasive aspergillosis--from the pathogen to the disease.深入了解侵袭性曲霉病——从病原体到疾病。
Curr Pharm Des. 2013;19(20):3679-88. doi: 10.2174/13816128113199990366.
2
Aspergillus fumigatus: contours of an opportunistic human pathogen.烟曲霉:机会性人类病原体的轮廓。
Cell Microbiol. 2010 Nov;12(11):1535-43. doi: 10.1111/j.1462-5822.2010.01517.x. Epub 2010 Sep 16.
3
Implications of hypoxic microenvironments during invasive aspergillosis.缺氧微环境对侵袭性曲霉病的影响。
Med Mycol. 2011 Apr;49 Suppl 1(Suppl 1):S120-4. doi: 10.3109/13693786.2010.495139. Epub 2010 Jun 21.
4
Aspergillus fumigatus and Aspergillosis in 2019.2019 年烟曲霉和曲霉病。
Clin Microbiol Rev. 2019 Nov 13;33(1). doi: 10.1128/CMR.00140-18. Print 2019 Dec 18.
5
New advances in invasive aspergillosis immunobiology leading the way towards personalized therapeutic approaches.侵袭性曲霉病免疫生物学的新进展引领个性化治疗方法的发展方向。
Cytokine. 2016 Aug;84:63-73. doi: 10.1016/j.cyto.2016.05.015. Epub 2016 May 30.
6
The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection.宿主与烟曲霉肺部感染病原体之间的免疫相互作用。
Biomed Res Int. 2013;2013:693023. doi: 10.1155/2013/693023. Epub 2013 Jul 30.
7
Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench.宿主对烟曲霉的免疫反应:从床边到实验台。
Future Microbiol. 2011 Jan;6(1):73-83. doi: 10.2217/fmb.10.158.
8
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance.探索烟曲霉生物膜、感染、免疫反应和抗真菌耐药性的交集。
Mycoses. 2023 Sep;66(9):737-754. doi: 10.1111/myc.13619. Epub 2023 May 22.
9
Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection.(免疫抑制状态下的)敌人:烟曲霉感染发病机制的最新研究进展。
Br J Haematol. 2010 Aug;150(4):406-17. doi: 10.1111/j.1365-2141.2010.08283.x. Epub 2010 Jul 7.
10
Identification and Characterization of a Novel Aspergillus fumigatus Rhomboid Family Putative Protease, RbdA, Involved in Hypoxia Sensing and Virulence.新型烟曲霉类菱形蛋白酶RbdA的鉴定与特性分析,该酶参与缺氧感知和毒力调控
Infect Immun. 2016 May 24;84(6):1866-1878. doi: 10.1128/IAI.00011-16. Print 2016 Jun.

引用本文的文献

1
Lactate Levels in a Replanted Limb as an Early Biomarker for Assessing Post-Surgical Evolution: A Case Report.再植肢体中的乳酸水平作为评估术后进展的早期生物标志物:一例报告
Diagnostics (Basel). 2025 Mar 11;15(6):688. doi: 10.3390/diagnostics15060688.
2
Drug-Resistant spp.: A Literature Review of Its Resistance Mechanisms and Its Prevalence in Europe.耐药菌:欧洲耐药机制及其流行情况的文献综述
Pathogens. 2023 Oct 31;12(11):1305. doi: 10.3390/pathogens12111305.
3
Soil Species, Pathogenicity and Control Perspectives.土壤 物种、致病性及防治观点
J Fungi (Basel). 2023 Jul 20;9(7):766. doi: 10.3390/jof9070766.
4
and the Interplay with Amphotericin B: from Resistance to Tolerance?与两性霉素 B 的相互作用:从耐药到耐受?
Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0227421. doi: 10.1128/aac.02274-21. Epub 2022 Mar 7.
5
Polyhydroxyalkanoate/Antifungal Polyene Formulations with Monomeric Hydroxyalkanoic Acids for Improved Antifungal Efficiency.含单体羟基链烷酸的聚羟基链烷酸酯/抗真菌多烯制剂,用于提高抗真菌效率。
Antibiotics (Basel). 2021 Jun 18;10(6):737. doi: 10.3390/antibiotics10060737.
6
and aspergillosis: From basics to clinics.以及曲霉病:从基础到临床
Stud Mycol. 2021 May 10;100:100115. doi: 10.1016/j.simyco.2021.100115. eCollection 2021 Sep.
7
Cryptic species of section display essential physiological features to cause infection and are similar in their virulence potential in .节的隐种显示出引起感染的基本生理特征,在毒力潜力方面也相似。
Virulence. 2019 Dec;10(1):542-554. doi: 10.1080/21505594.2019.1614382.
8
Klebsiella pneumoniae prevents spore germination and hyphal development of Aspergillus species.肺炎克雷伯菌可阻止各类曲霉菌种的孢子萌发和菌丝生长。
Sci Rep. 2019 Jan 18;9(1):218. doi: 10.1038/s41598-018-36524-8.
9
Additional oxidative stress reroutes the global response of Aspergillus fumigatus to iron depletion.额外的氧化应激会改变烟曲霉对缺铁的全局反应。
BMC Genomics. 2018 May 10;19(1):357. doi: 10.1186/s12864-018-4730-x.
10
MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method.采用CLSI肉汤微量稀释法测定两性霉素B、伊曲康唑、伏立康唑、泊沙康唑和卡泊芬净对20种致病性丝状真菌的最低抑菌浓度(MIC)分布及杀菌活性评估。
J Fungi (Basel). 2017 May 31;3(2):27. doi: 10.3390/jof3020027.